224 related articles for article (PubMed ID: 12608525)
1. Treatment of obesity: an update on anti-obesity medications.
Halpern A; Mancini MC
Obes Rev; 2003 Feb; 4(1):25-42. PubMed ID: 12608525
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of obesity.
Mancini MC; Halpern A
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):377-89. PubMed ID: 16767304
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic options for the treatment of obesity.
Campbell ML; Mathys ML
Am J Health Syst Pharm; 2001 Jul; 58(14):1301-8. PubMed ID: 11471477
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for obesity.
Ioannides-Demos LL; Proietto J; McNeil JJ
Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
[TBL] [Abstract][Full Text] [Related]
5. Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
Ryan DH
Endocrine; 2000 Oct; 13(2):193-9. PubMed ID: 11186220
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of obesity.
Bray GA
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr; 13(1):131-48. PubMed ID: 10932681
[TBL] [Abstract][Full Text] [Related]
7. Diabesity: are weight loss medications effective?
Halpern A; Mancini MC
Treat Endocrinol; 2005; 4(2):65-74. PubMed ID: 15783244
[TBL] [Abstract][Full Text] [Related]
8. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
9. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
11. Obesity: pathophysiology and clinical management.
Gurevich-Panigrahi T; Panigrahi S; Wiechec E; Los M
Curr Med Chem; 2009; 16(4):506-21. PubMed ID: 19199918
[TBL] [Abstract][Full Text] [Related]
12. Obesity.
Arterburn D
Clin Evid; 2004 Jun; (11):762-76. PubMed ID: 15652036
[No Abstract] [Full Text] [Related]
13. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.
Glazer G
Arch Intern Med; 2001 Aug 13-27; 161(15):1814-24. PubMed ID: 11493122
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
[TBL] [Abstract][Full Text] [Related]
15. Three controlled trials of weight loss with phenylpropanolamine.
Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
[TBL] [Abstract][Full Text] [Related]
16. A concise review on the therapeutics of obesity.
Bray GA
Nutrition; 2000 Oct; 16(10):953-60. PubMed ID: 11054601
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: pharmacologic treatment of obesity.
Li Z; Maglione M; Tu W; Mojica W; Arterburn D; Shugarman LR; Hilton L; Suttorp M; Solomon V; Shekelle PG; Morton SC
Ann Intern Med; 2005 Apr; 142(7):532-46. PubMed ID: 15809465
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of obesity in children and adolescents: current status and perspectives.
Catoira N; Nagel M; Di Girolamo G; Gonzalez CD
Expert Opin Pharmacother; 2010 Dec; 11(18):2973-83. PubMed ID: 20958104
[TBL] [Abstract][Full Text] [Related]
19. [Anti-obesity drugs: sibutramine and orlistat].
Sempere I Verdú E; Palop Larrea V; Hidalgo Mora JJ; Martínez-Mir I
Med Clin (Barc); 2002 Mar; 118(11):437; author reply 437-8. PubMed ID: 11943108
[No Abstract] [Full Text] [Related]
20. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
